Sabate, Arlene F.

HRN: 24-46-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/26/2024
03/01/2024
IV
600mg
Q6hrs
DM Foot
Waiting Final Action 
01/26/2024
CEFTAZIDIME 1GM (VIAL)
01/26/2024
03/01/2024
IV
1 Gram
Q8hrs
DM Foot, Left
Waiting Final Action 
02/05/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/05/2024
02/12/2024
IV
600 Mg
Q 6 Hrs
Nonhealing Wound
Waiting Final Action 
02/05/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
02/05/2024
02/12/2024
TOPICAL
Topical
OD
For Debridement
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: